Stock Taper
SCREENER COMPARE ANY 2 STOCKS
STLNW
STARLING ONCOLOGY INC. WT
NASDAQ
$0.06
▼ DOWN 20.29% (-0.01)

KEY STATISTICS

Market Cap$5.50 M
52w High$0.06
52w Low$0.04
Dividend Yield—
Frequency—
P/E-0.18
Volume718
Shares Out.99.98M

COMPANY

LEADERSHIP

Daniel Virnich
CHIEF EXECUTIVE
Daniel Virnich

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 4, 2026
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
641

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$168.64M
NOV
11
WED

PRICE

$0.06 ▼ DOWN 20.29% (−$0.01)
$0.04$0.05$0.05$0.069:32 AM9:56 AM10:20 AM10:44 AM11:07 AM11:31 AM11:55 AM0.06

About Starling Oncology Inc. Wt

https://www.starlingoncology.com ↗

The Oncology Institute, Inc. provides comprehensive oncology services—including physician care, infusion, pharmacy, clinical trials, and support programs—for adult and senior cancer patients across the U.S. through its specialty pharmacy, patient ...

INDUSTRY

Medical - Care Facilities

A SERVICE STARLING ONCOLOGY INC. WT IS KNOWN FOR

Value-Based Cancer Care

The Oncology Institute offers specialized, value-based cancer care in community settings, including advanced treatments, clinical trials, and personalized care plans.

COMPETITORS

COMPETITOR
AGL COMPARE
ALHC COMPARE
EVH COMPARE

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2